• One-Stop CAR-T Therapy Development
  • Biomarker Identification & Selection
  • ScFv Generation
  • CAR Design & Construction
  • CAR-T Gene Packaging & Delivery
  • Replication-Competent Virus Testing
  • CAR Cell In Vitro Assay
  • CAR-T Preclinical In Vivo Assay
  • IND Development for CAR-T Cell Therapy
  • GMP Production for CAR-T Products
  • CAR Clinical Trial
  • One-Stop Canine CAR-T Therapy Development
  • One-Stop mRNA CAR-T Therapy Development
  • TRAC-CAR-T Cell Development
  • Modular CAR-T Cell Generation
  • One-Stop Silence™ CAR-T Cell Development
  • Vaccine Boosting CAR-T Cell Therapy
  • STAb-T Cell Therapy Development
  • CAR-T Therapy Development in the Non-Cancer Field
  • Anti-HIV CAR Cell Therapy Development
  • T Cell Activity Modulator Discovery
  • T Cell Programming
  • Virus Specific T Cell (VST) Development
  • Antibody-Coupled T Cell Receptor (ACTR) Development
  • Organoid-induced hPSC-original T Cell Differentiation
  • γδ T Cell Engineering
  • CAR-T CDMO
• One-Stop TCR-T Therapy Development
  • TCR Biomarker Identification & Selection
  • TCR Generation & Optimization
  • TCR Design & Construction
  • TCR Gene Packaging & Delivery
  • TCR In Vitro Assay
  • TCR-T Preclinical In Vivo Assay
  • TCR Clinical Application
  • TCR Analysis
  • TCR Tetramerization Construction
  • ScFv-TCR T Cell Therapy Development
  • AbTCR Development
  • Bispecific TCR Development
  • CER Development
• One-Stop CAR-MA Therapy Development
• One-Stop CAR-NK Therapy Development
  • One-Stop CAR-NKT Therapy Development
  • One-Stop UniCAR-NK Therapy Development
  • iPSC-derived CAR-NK Therapy Development
  • One-Stop TCR-NK Therapy Development
  • NK Cell Genetic Engineering
  • NK Cell Expansion
• One-Stop CAR-B Therapy Development
• One-Stop CAR-Monocyte Therapy Development
• One-Stop Cytokine Release Syndrome (CRS) Management
• TCR-Like Antibody Development
  • MHC/Peptide Complex Production
  • TCR-Like Antibody Discovery
  • TCR-Like Antibody Affinity Characterization
  • TCR-Like CAR Construction & Evaluation
• In Vivo Cell Engineering Development
  • In Vivo CAR-T Cell Engineering
  • In Vivo B Cell Engineering
  • In Vivo CAR-NK Cell Engineering
  • In Vivo CAR-M Cell Engineering
• One-Stop Allogeneic Cell Therapy Development
  • Allogeneic CAR-T Therapy Development
  • Allogeneic TCR-T Therapy Development
  • Allogeneic CAR-NK Therapy Development
  • Allogeneic CAR/TCR Cell Design & Engineering
  • Other Allogeneic Cell Therapy Development
• TCR/CAR/Antigen-Engineered Tregs Development
  • CAR-Treg Development
• Cancer Vaccine Development
  • Cancer Vaccine Discovery
  • Cancer Vaccine Engineering
  • Cancer Vaccine Analytical Characterization
  • Cancer Vaccine In Vivo Assessment
  • Cancer Vaccine GMP Manufacturing
  • Dendritic Cell Vaccine Development
• Immune Genotyping
  • HLA Typing
  • KIR Typing
  • HLA Testing
  • Dog DLA Genotyping
  • Guinea Pig GPLA Genotyping
  • Mouse H2 Genotyping
  • Rabbit RLA Genotyping
  • Rat RT1 Genotyping
  • Rhesus Macaque MHC Genotyping
• Other Services
  • Tumor-infiltrating Lymphocyte-based Antibody Discovery

Electroporation Service

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Creative Biolabs offers optimized electroporation gene transfer service for modifying T cells genetically. As a non-viral gene transfer system, electroporation performs high transfection efficiency and low toxicity compared with other non-viral gene transfer methods used for primary lymphocytes, such as liposome. It can also accelerate gene transfer without the potential safety issues from viral vectors.

There are two classes of methods for DNA transfer: natural methods and artificial methods (including physical methods, chemical methods and electrical methods). Electroporation, along with electrofusion, belong to electrical methods. Electrical methods share similar mechanism: the reversible electropermeabilization of biological membranes. Electroporation employs high-voltage electrical pulse to introduce agents into cells. Just as shown in the figure, E-field (electric field) is used to introduce microscopic pores in biological membranes. Then these microscopic pores, electropores, allow different agents such as small molecules, ions to pass from one side of the membrane to the other. When a suitable pulse is given, the pores can reseal with molecules inside and the cells recover. Compare with some other gene transfer strategies, the approach of electroporation has several advantages: its process is fast and less costly. It is applied for a number of cell types and can treat various cells simultaneously. Moreover, by this method, high percentage of stable transformants can be produced. Considering these advantages, electroporation has various applications including: (1) to introduce exogenous DNA into bacterial protoplast, yeast protoplast, plant protoplast and animal cell line; (2) to increase efficiency of transfection or transformation of different cells; (3) to transform plant cells including wheat, tobacco, rice, maize with frequency up to 1%; (4) to introduce DNA into early embryo to produce transgenic animals; (5) to generate transient expression of molecular constructs. In terms of mammalian transgenesis, electroporation has been used to transfer exogenous DNA into cultured mammalian embryos at defined stages of development. Similarly, bovine blastocysts and fish species can also be genetically manipulated by the method of electroporation. Besides to facilitate gene transfer in both large and small animals, electroporation is reported to increase gene expression and improve immune response elicited to DNA vaccines.

The electroporation methods include:

• • Plasmid DNA electroporation
• • Nucleofection
• • RNA electroporation

The most popular strategies used for TCR gene transfer:

References:

K.H.KHAN. Gene Transfer Technologies and their Applications: Roles in Human Diseases. ASIAN J. EXP. BIOL. SCI. VOl 1 (1) 2010:208-218.

To discuss your demands or to request a proposal, please contact us by .